As of Apr 28
| -0.20 / -1.33%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 13.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a -8.78% decrease from the last price of 14.80.
The current consensus among 7 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.